“This strategy was developed by the Armed Services Biomedical Research Evaluation and Management (ASBREM) Community of Interest (CoI), which represents 20 participating departments and agencies across the Department of Defense (DoD) that perform or sponsor biomedical research and development (R&D). This document outlines the overall strategy for achieving the biomedical advances necessary for ensuring that the U.S. Armed Forces are ready to meet future health services challenges with optimized health, enhanced…” Read the full post here.
Source: The Integrated DoD Biomedical Research and Development Strategy – By Joseph Cohn, May 13, 2018.
